LymphoStat-B also significantly reduced disease activity across multiple clinical measures. In the mid-stage clinical trial, SLE patients given LymphoStat-B showed reduced disease activity after 52 weeks. Additionally, more
The DiabeCell trial is being conducted in six type 1 (insulin-dependent) diabetics. Recipients in this first trial are given the lowest clinically effective dose to demonstrate safety and
The company is developing PLX cells, which are Pluristem’s placental-derived mesenchymal stem cells that have been expanded in the company’s proprietary PluriX 3-D bioreactor. The in vitro assay
Data from the study also showed that Cimzia given every four weeks as monotherapy is significantly more efficacious than placebo in the treatment of patients with active rheumatoid
Rimonabant, the active ingredient of the drug, is currently approved in 37 countries and is marketed in 18. In those countries where it is currently sold, the product
Lupin's trandolapril tablets are the AB-rated generic equivalent of Abbott's Mavik tablets, indicated for the treatment of hypertension. The brand product had annual sales of approximately $49 million
However, the National Institute for Health and Clinical Excellence (NICE) has recommended against a rival product, Macugen, which is marketed by Pfizer and Eyetech. The guidance also suggests
The partnership will be a not-for-profit, drug-research organization based in Seattle, which will draw upon resources from some of the nation's leading tuberculosis (TB) and infectious diseases drug
Pursuant to the terms of the letter of intent, AOB has 90 days to enter into a definitive purchase agreement and close the transaction with CCXA. The company
The lawsuit was filed in 2005 in the US District Court for the District of Columbia, and will continue to move forward for Barr. According to the complaint,
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.